Research Report Analysis Bioinformatics Technologies and Global Markets

1

• Bioinformatics Technologies and Global Markets

2
The global bioinformatic market was 3.6 billion
and 4.1 billion in 2013 and 2014, respectively.
This market is expected to reach 8.0 billion in
2019 from 4.7 billion in 2015 at a compound
annual growth rate of 14.2 for the period
2014-2019. The report provides -An overview of
the global market for bioinformatics based on
geography, category and application. -Analyses
of global market trends, with data from 2013 and
2014, estimates for 2015, and projections of
compound annual growth rates (CAGRs) through
2019. -Technological descriptions and patenting
trends in bioinformatics. -Analysis of the
market's dynamics, including opportunities,
drivers, and restraints. -Examination of the
economic environment effecting the deployment of
bioinformatics. -Discussion of other influential
factors, such as RD spending in the
pharmaceutical sector, the growth of
agrobiotechnology, and the expanded use of
microbial genomics. -Comprehensive company
profiles of major players in the industry.
3

INTRODUCTION STUDY GOALS AND OBJECTIVES Research
s goal for this study is to provide a
comprehensive analysis of the bioinformatic
market by reviewing the recent advances in
high-throughput omic platforms and
computer-enabled tools that drive the field
forward. It examines the market trends and
provides analysis regarding industry service
providers and software solution developers, as
well as IT and bioinformatics service providers
that support the pharma and biotech
industry. The reports main focus is to identify
the challenges and opportunities that exist in
the bioinformatic market following the adoption
of high-throughput technologies such as
next-generation sequencing (NGS), the analysis of
big data and the emergence of cloud-based
solutions. It identifies innovative companies and
technologies that are moving the field forward
and enabling scientists to search for elusive
pieces of information that will improve diagnosis
and treatment with precision medicines.
4

REASONS FOR DOING THE STUDY Since scientists
unraveled the blueprint of the human genome more
that 10 years ago, they have been exploring new
ways to utilize omic data to understand more
complex diseases. Researchers are keen to analyze
as many different types of data as possible to
gain a better understanding of that which is
happening at the cellular and molecular levels.
Service providers have developed new analytical
tools and information technology (IT)
infrastructures to enable scientists to
interrogate complex data sources and quickly and
efficiently disseminate information for better
decision making to achieve this goal. More
recently, improvements in cloud computing
capabilities and advances in data analysis
software services have helped to expand the
evaluation of available datasets, allowing
researchers to build systems biology models of
various diseases. There has recently been a
massive shift in the way people do computing in
part due to the availability of cloud computing
and the growth in NGS technologies, and as a
result, service providers are now offering more
cloud-based solutions on a pay-as-you-go or
fee-for-service manner to suit the budgets of
both small and larger business.
5
SCOPE OF REPORT The scope of the study
encompasses the global bioinformatic market based
on geography, category and application. It
provides a detailed analysis of recent advances
in omic technologies and examines their impact
on the bioinformatic market. It discusses the
ways in which bioinformatics has been utilized by
the pharma and biotech industry to streamline the
research and development (RD) process and
improve efficiencies. It provides a detailed
analysis of leading countries, companies and
technologies that will drive the field
forward. INTENDED AUDIENCE The study provides a
detailed analysis of the economic, technological
and potential application of bioinformatics it
also examines the market drivers and identifies
the potential opportunities through 2019. The
study is aimed at the pharmaceutical industry,
biotechnology firms, research laboratories and
individuals interested in exploiting the
commercial opportunities offered in this field.

6
SCOPE OF REPORT The scope of the study
encompasses the global bioinformatic market based
on geography, category and application. It
provides a detailed analysis of recent advances
in omic technologies and examines their impact
on the bioinformatic market. It discusses the
ways in which bioinformatics has been utilized by
the pharma and biotech industry to streamline the
research and development (RD) process and
improve efficiencies. It provides a detailed
analysis of leading countries, companies and
technologies that will drive the field
forward. INTENDED AUDIENCE The study provides a
detailed analysis of the economic, technological
and potential application of bioinformatics it
also examines the market drivers and identifies
the potential opportunities through 2019. The
study is aimed at the pharmaceutical industry,
biotechnology firms, research laboratories and
individuals interested in exploiting the
commercial opportunities offered in this field.

7
Table of Contents

• Introduction - Complimentary 3 0
• Executive Summary 3 250
• Big Data What To Do With It? 17 1073
• Bioinformatics Data Generation And Data
  Management 31 1957
• Bioinformatics Data Analysis And Software 11
  694
• Bioinformatics Data Processing And Storage 11
  694
• Bioinformatic Applications In Pharmaceutical
  Research And Development 26 1641
• Market Trends And Analysis 24 1515
• Company Profiles 16 1010
• Appendix One Acronyms 2 126

W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
8
To view the full Executive Summary and Table
of Contents, please visit Bioinformatics
Technologies and Global Markets Contact
Us-Call India 91-22-27810772/73Email id
info_at_bharatbook.com Website www.bharatbook.com
Our Blog https//www.bharatbook.com/blog/


W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com